University of Rochester Medical Center
SearchDirectoryNewsEventsStrong HealthURMC Home


photo of James M. Powers

M.D. 1969
Medical Univesity of South Carolina

James M. Powers
  Professor of Pathology and Laboratory Medicine and Neurology

Primary Appointment:
  Pathology

GEBS Cluster Affiliations:
  MOCB - Molecular Oncology and Cancer Biology
  NS - Neuroscience
 


Research:
  Peroxisomal Disorders

Contact Information:
  E-Mail: James_Powers@urmc.rochester.edu
University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 626
Rochester, New York 14642
Medical Center 1-6335
Phone: (716) 275-3202
Research Overview
The peroxisomal disorders are a heterogeneous group of human diseases in which lesions of the nervous and endocrine systems often predominate. Classical morphologic investigations of the two prototypic peroxisomal diseases, X-linked, juvenile adreno-leukodystrophy (ALD) and cerebro-hepato-renal (Zellweger) syndrome (CHRS), have provided some insights into the pathogenesis of these disorders. The major pathologic lesion in the nervous system of ALD patients is that of an inflammatory, demyelinative lesion of central white matter. The inflammatory component, a morphologic marker of disease activity, has been interwoven in ways unknown with a defect in very long chain fatty acid catabolism to produce the pathogenetic fabric of ALD. Recently, we have identified a number of effector molecules and cytokines in the early stages of these lesions, particularly TNF-a. Their primary source appears to be the hypertrophic astrocytes within these lesions. The hypothesis that a cytokine cascade may initiate and interact with a cell-mediated immune response has provided a new impetus for possible treatment of the devastating CNS demyelination in ALD patients.

The main pathologic alterations seen in Zellweger infants are those of a central neuronal migration defect and a non-inflammatory abnormality of central white matter. Neuronal migrations appear to be interrupted in the first trimester and throughout the entire neocortical migratory epoch. Preliminary ultrastructural observations suggest that both migrating neuroblasts and radial glia are affected. Additionally, there is a white matter abnormality in CHRS, the pathogenesis of which is still unclear. My current investigative interests include: 1) an elucidation of this white matter abnormality in CHRS; 2) to further elucidate the demyelinative lesion of ALD; and 3) to further our understanding of the spinal cord tract degeneration seen in adrenomyeloneuropathy, a variant of ALD.
Recent Publications

Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, smith KD: A mouse Model for X-linked Adrenoleukodystrophy Proc Natl Acad Sci 94:9366-9371, 1997.

McGuinness MC, Powers JM, Bias WB, Schmeckpeper BJ, Segal AH, Gowda VC, Wesselingh SL, Berger J, Griffin DE, Smith KD: Human Leukocyte Antigens and Cytokine Edpression in Cerebral Inflammatory Demyelinative Lesions of X-linked Adrenoleukodystrophy and Multiple Sclerosisl. J Neuroimmunol 75:174-182, 1997.

Powers, J.M. 1996. Neuropathologic overview of the neurodystrophies and neurolipidoses. Handbook Clin. Neurol. 22(66):1-31.

 



Back to Pathology

GEBS Clusters:
MOCB

NS